96 related articles for article (PubMed ID: 3282731)
1. Erythrocythemia following renal transplantation: influence of diuretic therapy.
Pollak R; Maddux MS; Cohan J; Jacobsson PK; Mozes MF
Clin Nephrol; 1988 Mar; 29(3):119-23. PubMed ID: 3282731
[TBL] [Abstract][Full Text] [Related]
2. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study.
Kessler M; Hestin D; Mayeux D; Mertes PM; Renoult E
Clin Nephrol; 1996 Feb; 45(2):83-9. PubMed ID: 8846535
[TBL] [Abstract][Full Text] [Related]
3. Erythrocytosis after renal transplantation. A prospective analysis.
Sumrani NB; Daskalakis P; Miles AM; Sarkar S; Markell MS; Hong JH; Friedman EA; Sommer BG
ASAIO J; 1993; 39(1):51-5. PubMed ID: 8439681
[TBL] [Abstract][Full Text] [Related]
4. Factors predisposing to post-renal transplant erythrocytosis: a retrospective study.
Charfeddine K; Zaghdane S; Yaich S; Hakim A; Hachicha J
Saudi J Kidney Dis Transpl; 2008 May; 19(3):371-7. PubMed ID: 18445895
[TBL] [Abstract][Full Text] [Related]
5. Ramipril in post-renal transplant erythrocytosis.
Esposito R; Giammarino A; De Blasio A; Martinelli V; Cirillo F; Scopacasa F; Federico S; Russo D
J Nephrol; 2007; 20(1):57-62. PubMed ID: 17347974
[TBL] [Abstract][Full Text] [Related]
6. Factors inducing posttransplant erythrocytosis.
Lezaić V; Djukanović LJ; Pavlović-Kentera V; Clemons G; Biljanović-Paunović L
Eur J Med Res; 1997 Sep; 2(9):407-12. PubMed ID: 9300939
[TBL] [Abstract][Full Text] [Related]
7. Relationship of posttransplantation erythrocytosis to hypercalcemia in renal transplant recipients.
Akcay A; Kanbay M; Huddam B; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M
Transplant Proc; 2005 Sep; 37(7):3103-5. PubMed ID: 16213320
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up.
Torregrosa JV; Campistol JM; Montesinos M; Rogada AG; Oppenheimer F; Andreu J
Transplantation; 1994 Aug; 58(3):311-4. PubMed ID: 8053053
[TBL] [Abstract][Full Text] [Related]
9. Erythrocytosis after renal transplantation: risk factors and relationship with GFR.
Nankivell BJ; Allen RD; O'Connell PJ; Chapman JR
Clin Transplant; 1995 Oct; 9(5):375-82. PubMed ID: 8541630
[TBL] [Abstract][Full Text] [Related]
10. Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis.
Marubayashi S; Yamamoto H; Shibata S; Fudaba Y; Miyata Y; Fukuma K; Okada K; Hinoi T; Ikeda M; Maeda T; Oshiro Y; Dohi K
Hiroshima J Med Sci; 1998 Sep; 47(3):121-4. PubMed ID: 9810784
[TBL] [Abstract][Full Text] [Related]
11. Risk factors of erythrocytosis post renal transplantation.
Razeghi E; Kaboli A; Pezeshki ML; Meysamie AP; Khatami MR; Khashayar P
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):559-63. PubMed ID: 18580013
[TBL] [Abstract][Full Text] [Related]
12. Decreased plasma volume in post-transplant erythrocytosis.
Obermiller LE; Tzamaloukas AH; Avasthi PS; Halpern JA; Sterling WA
Clin Nephrol; 1985 May; 23(5):213-7. PubMed ID: 3891180
[TBL] [Abstract][Full Text] [Related]
13. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
[TBL] [Abstract][Full Text] [Related]
14. Serum stem cell factor level in renal transplant recipients with posttransplant erythrocytosis.
Kiykim AA; Genctoy G; Horoz M; Tiftik NE; Gok E; Altun B; Arici M; Haznedaroglu I
Artif Organs; 2009 Dec; 33(12):1086-90. PubMed ID: 19958348
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme gene polymorphism and development of post-transplant erythrocytosis.
Yildiz A; Yazici H; Cine N; Kazancioglu R; Akkaya V; Sever MS; Ark E; Erginel-Unaltuna N
J Nephrol; 2003; 16(3):399-403. PubMed ID: 12832741
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin production after kidney transplantation.
Gaciong Z; Koziak K; Jarzyło I; Ludwicki K; Malanowska S; Paczek L; Szmidt J; Wałaszewski J; Lao M
Ann Transplant; 1996; 1(1):29-33. PubMed ID: 9869934
[TBL] [Abstract][Full Text] [Related]
17. Anemia due to losartan in hypertensive renal transplant recipients without posttransplant erythrocytosis.
Ersoy A; Kahvecioglu S; Ersoy C; Cift A; Dilek K
Transplant Proc; 2005 Jun; 37(5):2148-50. PubMed ID: 15964363
[TBL] [Abstract][Full Text] [Related]
18. Influence of angiotensin I-converting enzyme polymorphism on development of post-transplant erythrocytosis in renal graft recipients.
Kedzierska K; Kabat-Koperska J; Safranow K; Domański M; Gołembiewska E; Bober J; Bohatyrewicz R; Ciechanowski K
Clin Transplant; 2008; 22(2):156-61. PubMed ID: 18339134
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
20. Serum erythropoietin activity following kidney transplantation.
Vedovato M; Salvatorelli G; De Paoli Vitali E; Farinelli A; Limone GL; Panzavolta R
Haematologia (Budap); 1990; 23(1):21-5. PubMed ID: 2204593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]